GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (FRA:PYPB) » Definitions » Valuation Rank

IXICO (FRA:PYPB) Valuation Rank


View and export this data going back to . Start your Free Trial

What is IXICO Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

IXICO Valuation Rank Related Terms

Thank you for viewing the detailed overview of IXICO's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

IXICO (FRA:PYPB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (FRA:PYPB) » Definitions » Valuation Rank
Comparable Companies
LSE:TCF LSE:FAB LSE:APTA LSE:VAL LSE:OCTP LSE:BSFA LSE:PYC AQSE:PBX LSE:NFX LSE:CIZ OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
IXI:UK
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
Website
https://www.ixico.com
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.